{"id":46460,"date":"2022-07-21T23:01:55","date_gmt":"2022-07-21T21:01:55","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/iveric-bio-to-report-second-quarter-2022-financial-results-and-host-conference-call-on-tuesday-july-26-2022\/"},"modified":"2022-07-21T23:01:55","modified_gmt":"2022-07-21T21:01:55","slug":"iveric-bio-to-report-second-quarter-2022-financial-results-and-host-conference-call-on-tuesday-july-26-2022","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/iveric-bio-to-report-second-quarter-2022-financial-results-and-host-conference-call-on-tuesday-july-26-2022\/","title":{"rendered":"Iveric Bio to Report Second Quarter 2022 Financial Results and Host Conference Call on Tuesday, July 26, 2022"},"content":{"rendered":"
\n

PARSIPPANY, N.J.–(BUSINESS WIRE)–IVERIC bio, Inc.<\/a> (Nasdaq: ISEE) today announced that it will report its second quarter 2022 financial and operating results on Tuesday, July 26, 2022. Following the announcement, the Iveric Bio management team will host a live conference call and webcast at 8:00 a.m. Eastern Time to discuss the Company\u2019s financial results and provide a general business update.\n<\/p>\n

<\/a><\/p>\n

\nTo participate in this conference call, dial 1-888-317-6003 (USA) or 1-412-317-6061 (International), passcode 0932671. A live, listen-only audio webcast of the conference call can be accessed on the Investors section of the Iveric Bio website at www.ivericbio.com<\/a>. A replay will be available approximately two hours following the live call for two weeks. The replay number is 1-877-344-7529 (USA Toll Free), passcode 6585313.\n<\/p>\n

\nAbout Iveric Bio
\n
<\/b>Iveric Bio is a science-driven biopharmaceutical company focused on the discovery and development of novel treatments for retinal diseases with significant unmet medical needs. The Company is committed to having a positive impact on patients\u2019 lives by delivering high-quality, safe and effective treatments designed to address debilitating retinal diseases including earlier stages of age-related macular degeneration. For more information on the Company, please visit www.ivericbio.com<\/a>.\n<\/p>\n

\nForward-looking Statements
\n
<\/i><\/b>Any statements in this press release about Iveric Bio\u2019s future expectations, plans and prospects constitute forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors. Any forward-looking statements represent Iveric Bio\u2019s views only as of the date of this press release. Iveric Bio anticipates that subsequent events and developments will cause its views to change. While Iveric Bio may elect to update these forward-looking statements at some point in the future, Iveric Bio specifically disclaims any obligation to do so.<\/i>\n<\/p>\n

\nISEE-G<\/b>\n<\/p>\n

Contacts<\/b> <\/p>\n

\nInvestor Contact:<\/b>
Kathy Galante
\n
Senior Vice President, Investor Relations
\n
kathy.galante@ivericbio.com<\/a>\n<\/p>\n

\nMedia Contact:<\/b>
Jeannie Neufeld
\n
Senior Director, Public Relations & Communications
\n
jeannie.neufeld@ivericbio.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

PARSIPPANY, N.J.–(BUSINESS WIRE)–IVERIC bio, Inc. (Nasdaq: ISEE) today announced that it will report its second quarter 2022 financial and operating results on Tuesday, July 26, 2022. Following the announcement, the Iveric Bio management team will host a live conference call and webcast at 8:00 a.m. Eastern Time to discuss the Company\u2019s financial results and provide … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-46460","6":"format-standard","7":"category-industry"},"yoast_head":"\nIveric Bio to Report Second Quarter 2022 Financial Results and Host Conference Call on Tuesday, July 26, 2022 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/iveric-bio-to-report-second-quarter-2022-financial-results-and-host-conference-call-on-tuesday-july-26-2022\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Iveric Bio to Report Second Quarter 2022 Financial Results and Host Conference Call on Tuesday, July 26, 2022 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"PARSIPPANY, N.J.–(BUSINESS WIRE)–IVERIC bio, Inc. (Nasdaq: ISEE) today announced that it will report its second quarter 2022 financial and operating results on Tuesday, July 26, 2022. Following the announcement, the Iveric Bio management team will host a live conference call and webcast at 8:00 a.m. Eastern Time to discuss the Company\u2019s financial results and provide ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/iveric-bio-to-report-second-quarter-2022-financial-results-and-host-conference-call-on-tuesday-july-26-2022\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-21T21:01:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220721006007\/en\/1151895\/21\/Iveric_Bio_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iveric-bio-to-report-second-quarter-2022-financial-results-and-host-conference-call-on-tuesday-july-26-2022\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iveric-bio-to-report-second-quarter-2022-financial-results-and-host-conference-call-on-tuesday-july-26-2022\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Iveric Bio to Report Second Quarter 2022 Financial Results and Host Conference Call on Tuesday, July 26, 2022\",\"datePublished\":\"2022-07-21T21:01:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iveric-bio-to-report-second-quarter-2022-financial-results-and-host-conference-call-on-tuesday-july-26-2022\\\/\"},\"wordCount\":353,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iveric-bio-to-report-second-quarter-2022-financial-results-and-host-conference-call-on-tuesday-july-26-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220721006007\\\/en\\\/1151895\\\/21\\\/Iveric_Bio_Logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iveric-bio-to-report-second-quarter-2022-financial-results-and-host-conference-call-on-tuesday-july-26-2022\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iveric-bio-to-report-second-quarter-2022-financial-results-and-host-conference-call-on-tuesday-july-26-2022\\\/\",\"name\":\"Iveric Bio to Report Second Quarter 2022 Financial Results and Host Conference Call on Tuesday, July 26, 2022 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iveric-bio-to-report-second-quarter-2022-financial-results-and-host-conference-call-on-tuesday-july-26-2022\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iveric-bio-to-report-second-quarter-2022-financial-results-and-host-conference-call-on-tuesday-july-26-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220721006007\\\/en\\\/1151895\\\/21\\\/Iveric_Bio_Logo.jpg\",\"datePublished\":\"2022-07-21T21:01:55+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iveric-bio-to-report-second-quarter-2022-financial-results-and-host-conference-call-on-tuesday-july-26-2022\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iveric-bio-to-report-second-quarter-2022-financial-results-and-host-conference-call-on-tuesday-july-26-2022\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iveric-bio-to-report-second-quarter-2022-financial-results-and-host-conference-call-on-tuesday-july-26-2022\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220721006007\\\/en\\\/1151895\\\/21\\\/Iveric_Bio_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220721006007\\\/en\\\/1151895\\\/21\\\/Iveric_Bio_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iveric-bio-to-report-second-quarter-2022-financial-results-and-host-conference-call-on-tuesday-july-26-2022\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Iveric Bio to Report Second Quarter 2022 Financial Results and Host Conference Call on Tuesday, July 26, 2022\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Iveric Bio to Report Second Quarter 2022 Financial Results and Host Conference Call on Tuesday, July 26, 2022 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/iveric-bio-to-report-second-quarter-2022-financial-results-and-host-conference-call-on-tuesday-july-26-2022\/","og_locale":"en_US","og_type":"article","og_title":"Iveric Bio to Report Second Quarter 2022 Financial Results and Host Conference Call on Tuesday, July 26, 2022 - Pharma Trend","og_description":"PARSIPPANY, N.J.–(BUSINESS WIRE)–IVERIC bio, Inc. (Nasdaq: ISEE) today announced that it will report its second quarter 2022 financial and operating results on Tuesday, July 26, 2022. Following the announcement, the Iveric Bio management team will host a live conference call and webcast at 8:00 a.m. Eastern Time to discuss the Company\u2019s financial results and provide ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/iveric-bio-to-report-second-quarter-2022-financial-results-and-host-conference-call-on-tuesday-july-26-2022\/","og_site_name":"Pharma Trend","article_published_time":"2022-07-21T21:01:55+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220721006007\/en\/1151895\/21\/Iveric_Bio_Logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/iveric-bio-to-report-second-quarter-2022-financial-results-and-host-conference-call-on-tuesday-july-26-2022\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/iveric-bio-to-report-second-quarter-2022-financial-results-and-host-conference-call-on-tuesday-july-26-2022\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Iveric Bio to Report Second Quarter 2022 Financial Results and Host Conference Call on Tuesday, July 26, 2022","datePublished":"2022-07-21T21:01:55+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/iveric-bio-to-report-second-quarter-2022-financial-results-and-host-conference-call-on-tuesday-july-26-2022\/"},"wordCount":353,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/iveric-bio-to-report-second-quarter-2022-financial-results-and-host-conference-call-on-tuesday-july-26-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220721006007\/en\/1151895\/21\/Iveric_Bio_Logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/iveric-bio-to-report-second-quarter-2022-financial-results-and-host-conference-call-on-tuesday-july-26-2022\/","url":"https:\/\/pharma-trend.com\/en\/iveric-bio-to-report-second-quarter-2022-financial-results-and-host-conference-call-on-tuesday-july-26-2022\/","name":"Iveric Bio to Report Second Quarter 2022 Financial Results and Host Conference Call on Tuesday, July 26, 2022 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/iveric-bio-to-report-second-quarter-2022-financial-results-and-host-conference-call-on-tuesday-july-26-2022\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/iveric-bio-to-report-second-quarter-2022-financial-results-and-host-conference-call-on-tuesday-july-26-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220721006007\/en\/1151895\/21\/Iveric_Bio_Logo.jpg","datePublished":"2022-07-21T21:01:55+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/iveric-bio-to-report-second-quarter-2022-financial-results-and-host-conference-call-on-tuesday-july-26-2022\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/iveric-bio-to-report-second-quarter-2022-financial-results-and-host-conference-call-on-tuesday-july-26-2022\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/iveric-bio-to-report-second-quarter-2022-financial-results-and-host-conference-call-on-tuesday-july-26-2022\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220721006007\/en\/1151895\/21\/Iveric_Bio_Logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220721006007\/en\/1151895\/21\/Iveric_Bio_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/iveric-bio-to-report-second-quarter-2022-financial-results-and-host-conference-call-on-tuesday-july-26-2022\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Iveric Bio to Report Second Quarter 2022 Financial Results and Host Conference Call on Tuesday, July 26, 2022"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46460","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=46460"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46460\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=46460"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=46460"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=46460"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}